XULANE LO-E Trademark

Trademark Overview


On Tuesday, April 23, 2024, a trademark application was filed for XULANE LO-E with the United States Patent and Trademark Office. The USPTO has given the XULANE LO-E trademark a serial number of 98514712. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, December 10, 2024. This trademark is owned by Mylan Pharmaceuticals Inc.. The XULANE LO-E trademark is filed in the Pharmaceutical Products category with the following description:

Transdermal contraceptives
xulane lo-e

General Information


Serial Number98514712
Word MarkXULANE LO-E
Filing DateTuesday, April 23, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, December 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 10, 2024

Trademark Statements


Goods and ServicesTransdermal contraceptives

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 23, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMylan Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMorgantown, WV 26505

Party NameMylan Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMorgantown, WV 26505

Trademark Events


Event DateEvent Description
Tuesday, April 23, 2024NEW APPLICATION ENTERED
Wednesday, October 16, 2024ASSIGNED TO EXAMINER
Thursday, October 24, 2024NON-FINAL ACTION E-MAILED
Thursday, October 24, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 24, 2024NON-FINAL ACTION WRITTEN
Thursday, October 24, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 24, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 24, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 18, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 4, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 10, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 10, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 23, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords


xulane contraceptives transdermal